These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25920604)

  • 21. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy?
    Yao M; Hoffman HT; Chang K; Funk GF; Smith RB; Tan H; Clamon GH; Dornfeld K; Buatti JM
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):707-13. PubMed ID: 17379453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
    Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers.
    Kupferman ME; Morrison WH; Santillan AA; Roberts D; Diaz EM; Garden AS; Weber R
    Cancer; 2007 May; 109(10):2052-7. PubMed ID: 17407106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes.
    Mabanta SR; Mendenhall WM; Stringer SP; Cassisi NJ
    Head Neck; 1999 Oct; 21(7):591-4. PubMed ID: 10487944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
    Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
    JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns-of-failure after helical tomotherapy-based chemoradiotherapy for head and neck cancer: implications for CTV margin, elective nodal dose and bilateral parotid sparing.
    Dandekar V; Morgan T; Turian J; Fidler MJ; Showel J; Nielsen T; Coleman J; Diaz A; Sher DJ
    Oral Oncol; 2014 May; 50(5):520-6. PubMed ID: 24613544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional relapse after intensity-modulated radiotherapy for head-and-neck cancer.
    Duprez F; Bonte K; De Neve W; Boterberg T; De Gersem W; Madani I
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):450-8. PubMed ID: 20381266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is neck dissection necessary after induction plus concurrent chemoradiotherapy in complete responder head and neck cancer patients with pretherapy advanced nodal disease?
    Da Mosto MC; Lupato V; Romeo S; Spinato G; Addonisio G; Baggio V; Gava A; Boscolo-Rizzo P
    Ann Surg Oncol; 2013 Jan; 20(1):250-6. PubMed ID: 22836557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of salvage selective and modified radical neck dissection for regional pathologic lymphadenopathy after chemoradiation.
    van der Putten L; van den Broek GB; de Bree R; van den Brekel MW; Balm AJ; Hoebers FJ; Doornaert P; Leemans CR; Rasch CR
    Head Neck; 2009 May; 31(5):593-603. PubMed ID: 19132716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary.
    Ligey A; Gentil J; Créhange G; Montbarbon X; Pommier P; Peignaux K; Truc G; Maingon P
    Radiother Oncol; 2009 Dec; 93(3):483-7. PubMed ID: 19892420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT.
    Nayak JV; Walvekar RR; Andrade RS; Daamen N; Lai SY; Argiris A; Smith RP; Heron DE; Ferris RL; Johnson JT; Branstetter BF
    Laryngoscope; 2007 Dec; 117(12):2129-34. PubMed ID: 17921898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancer.
    Maguire PD; Papagikos M; Hamann S; Neal C; Meyerson M; Hayes N; Ungaro P; Kotz K; Couch M; Pollock H; Tepper J
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1081-8. PubMed ID: 20378262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.
    Gourin CG; Boyce BJ; Williams HT; Herdman AV; Bilodeau PA; Coleman TA
    Laryngoscope; 2009 Nov; 119(11):2150-5. PubMed ID: 19544378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The management of the clinically positive neck as part of a larynx preservation approach.
    Armstrong J; Pfister D; Strong E; Heimann R; Kraus D; Polishook A; Zelefsky M; Bosl G; Shah J; Spiro R
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):759-65. PubMed ID: 8344843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of intensity-modulated radiotherapy for head and neck cancers in routine practice.
    Bednarek C; Nguyen TV; Puyraveau M; Bonnet É; Lescut N; Azélie C; Miny J; Mauvais O; Maurina T; Tochet F; Bosset JF; Thariat J; Sun XS
    Cancer Radiother; 2017 Feb; 21(1):21-27. PubMed ID: 28034680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).
    Fury MG; Sherman EJ; Rao SS; Wolden S; Smith-Marrone S; Mueller B; Ng KK; Dutta PR; Gelblum DY; Lee JL; Shen R; Kurz S; Katabi N; Haque S; Lee NY; Pfister DG
    Ann Oncol; 2014 Mar; 25(3):689-694. PubMed ID: 24496920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elective lymphadenectomy during salvage for locally recurrent head and neck squamous cell carcinoma after radiation.
    Prendes BL; Aubin-Pouliot A; Egbert N; Ryan WR
    Otolaryngol Head Neck Surg; 2014 Sep; 151(3):462-7. PubMed ID: 24894423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of the N0 neck during salvage surgery after radiotherapy of head and neck squamous cell carcinoma.
    Temam S; Koka V; Mamelle G; Julieron M; Carmantrant R; Marandas P; Janot F; Bourhis J; Luboinski B
    Head Neck; 2005 Aug; 27(8):653-8. PubMed ID: 16035097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recurrence sites following definitive intensity-modulated conformational radiotherapy of squamous-cell carcinomas of the upper aerodigestive tract].
    Yossi S; El Alouani C; Pointreau Y; Laccourreye L; Capitain O; Gustin P; Peyraga G; Septans AL; Jadaud É; Vinchon-Petit S; Cellier P; Autret D; Tuchais C
    Cancer Radiother; 2015 Apr; 19(2):73-81. PubMed ID: 25623256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemo-reirradiation in persistent/recurrent head and neck cancers.
    Nagar YS; Singh S; Datta NR
    Jpn J Clin Oncol; 2004 Feb; 34(2):61-8. PubMed ID: 15067097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.